Which research priorities for AD in 2024? Curative precision medicine vs preventive exposome-targeted medicine. Dear Colleagues, Dear Friends, In a recently published provocative perspective paper (DOI: 10.3389/fpubh.2024.1351732), Ian A. Myles, a NIH researcher, asks some good questions to our community which could help shaping our priorities. Currently, with the industry-led dramatic development of biologics and […]
Read More
Abstracts for oral and poster presentations will represent the core of the scientific program at this meeting. Abstracts pertaining to human atopic dermatitis and related fields including animal models are appropriate. Check out your submissions Register NOW!-25% Early bird rates are extended to Sep 10! Accepted Oral Presentation in the main program (in-person or remotely […]
Read More
#RAJKAMedal Rajka medal and prize: the winner among 7 excellent applicants from originating from China, Japan, Korea and Madagascar, is Dr Fang WANG, MD, PhD, Professor and Chief Physician at Sun Yat-Sen University, Guangzhou, China. Dr WANG has an outstanding CV and list of publications. She is a dermatologist with a strong background in neuroimmunology applied to […]
Read More
#RAJKA2024Doha #RAJKAMedal Dear Colleagues, Dear Friends, The abstract submission to the 14th Georg Rajka Symposium on AD (Doha, Qatar, October 24-26, 2024) closed as scheduled on July 15th. 149 abstracts from 32 countries were received. They are currently adjudicated, and the outcome will be available soon in second half of August. All accepted abstracts will be […]
Read More
What PubMed tell us about current trends in AD research? Dear Colleagues, Dear Friends, Since the approval of dupilumab for severe adult AD by the FDA in 2017, published AD research has been tremendously driven by RCTs and associated research concerning dupilumab and other new systemic/ topical therapies designed to control TH2 inflammation. The influence […]
Read More
The 2024 Rajka Medal and Prize will be attributed, please have a look at the criteria to apply, this year will be very competitive! From 2024, an accompanying prize of 15.000 EUR will be given to the awardee to contribute to further research at his/her institution. In memory of Professor Georg RAJKA and his pioneering […]
Read More
Dear Colleagues, Dear Friends, Our May 2024 newsletter features ISAD collaboration with ILDS on the World Skin Health Day (WSHD) in Guinea and Madagascar, a national program to promote skin health including AD in Mauritania, the opening of the RAJKA2024 Call for Abstracts (ISAD Doha) and a focus on its pre-meeting: Patient-Centered Care in Atopic […]
Read More
Organized by SOMADER May 22, 2024, Madagascar The ISAD is happy to participate to the next World Skin Health Day organized by the Malagasy Society of Dermatology (SOMADER) with a regional and global focus on AD challenges. This programme highlights also the new WHO policy around skin NTDs in low resource countries combined with the […]
Read More
May 11, 2024, Nouakchott, Mauritania ISAD Society President Alain TAÏEB visited Mauritania and met the members of the National Dermatology Society (SMD, President Prof BALL second rank right) on the occasion of very interesting meeting organized on May 11th jointly by the SMD and the Ministry of Health. Mariem KEBE (yellow, middle of second rank), […]
Read More
Dear Colleagues, Dear Friends, Our April 2024 newsletter features report on our One Health event, our Research Fellowships and the RAJKA 2024 Symposium in Doha, along with a curated selection of the latest publications on PubMed that are worth reading. Alain TAÏEBPresident ISAD Examining Atopic Dermatitis through the One Health concept REPORT ON OUR SPRING […]
Read More